Scientists Identify Biomarkers to Guide Hormone Therapy for Prostate Cancer
University of California San Francisco News Release May 11, 2017 A test commonly used in breast cancer has been found to also identify which patients with aggressive prostate cancer will...Read More
Advanced Prostate Cancer Treatment Failure Due to Cell Reprogramming
New York, NY (May 4, 2017)—Columbia University Medical Center (CUMC) researchers have discovered a molecular mechanism that reprograms tumor cells in patients with advanced prostate cancer, reducing their response to...Read More
Why has checkpoint immunotherapy been ineffective in treating prostate cancer?
Checkpoint immunotherapy, the relatively new type of cancer treatment making headlines for being able to seemingly cure some patients with melanoma and other cancers, has been notoriously ineffective in prostate...Read More
2017 AACR-Prostate Cancer Foundation Scholar-in-Training Award Recipients
The Prostate Cancer Foundation Scholar-in-Training Awards recognize promising young cancer researchers presenting outstanding proffered papers relating to advanced prostate cancer at the American Association for Cancer Research (AACR) Annual Meeting....Read More
Prostate Cancer Foundation Announces New Recipients of 2016 PCF Challenge Awards to Promote Research in Deadly Prostate Cancer
SANTA MONICA, CA Feb. 14, 2017 – The Prostate Cancer Foundation (PCF) today announced that it has granted eight new 2016 PCF Challenge Awards to advance treatments and cures for...Read More
VA Partners with Prostate Cancer Foundation to Expand Clinical Research
https://vimeo.com/737338762/0ec24693c4 WASHINGTON – As a national leader in oncology advancement and as the largest integrated healthcare system in the nation, the Department of Veterans Affairs (VA) today announced an important...Read More
Genetic Counseling Center Dedicated To Advanced Prostate Cancer Opens In Seattle
Prostate cancer is one of the most heritable forms of cancer. Hereditary mutations in “DNA repair” genes – BRCA1, BRCA2, and others – which are best known for their association...Read More
The Prostate Cancer Foundation’s 2016 Coffey-Holden Prostate Cancer Academy Meeting Accelerates Advances In The Understanding And Treatment Of Metastatic Prostate Cancer
The Prostate Cancer Foundation (PCF) has a legacy of not only funding the most impactful research in prostate cancer, but also creating new infrastructures, global knowledge networks, and research initiatives...Read More
2016 Movember Foundation – PCF Challenge Awards Fund Advances in Precision Treatment
Prostate Cancer Foundation Receives More Than $5 Million from the Movember Foundation 5 New Challenge Awards will Fund Investigations in Lethal Prostate Cancer SANTA MONICA, CA August 2, 2016 --...Read More
Metastatic Prostate Cancer Cases Skyrocket Increase May Be Due To More Lax Screening Or More Aggressive Disease
Highest increase among men ages 55 to 69, who could benefit the most from screening and early treatment. Disease is more advanced when finally diagnosed. "Screening saves lives," urologists stress....Read More